FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Center | Date | Time | Location |
---|---|---|---|
CDRH | March 5, 2004 | 9 a.m. - 4 p.m. | Hilton Washington
DC North |
Agenda:
The committee will discuss general issues surrounding the use of intraocular
lenses for correction of presbyopia after clear lens extraction. The committee
will address clinical study design elements including the risk/benefit ratio
for patients with various refractive errors, study sample size, the need for
control groups, inclusion/exclusion criteria, and the incidence of retinal detachment
and other complications.
Background material and meeting information will become available no later than the day before the meeting (Simply select the appropriate committee link).
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by February 24, 2004. On March 5, 2004, formal oral presentations
from the public will be scheduled between approximately 9:15 a.m. and 9:45 a.m.
Near the end of the committee discussion a second 30-minute open public session
will be conducted for interested persons to comment further on the discussion
topic. Time allotted for each presentation may be limited. Those desiring to
make formal oral presentations should notify the contact person before February
24, 2004, and submit a brief statement of the general nature of the evidence
or arguments they wish to present, the names and addresses of proposed participants,
and an indication of the approximate time requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised that the agency
is not responsible for providing access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact AnnMarie Williams 301-594-1283 ext. 113 at least 7 days in advance
of the meeting.
Contact Person:
Sara M. Thornton, Center for Devices and Radiological Health (HFZ-460), Food
and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2053,
ext. 127, or FDA Advisory Committee Information Line, 1-800-741-8138
(301-443-0572 in the Washington, DC area), code 3014512396. Please call the
Information Line for up-to-date information on this meeting.
[ Full FR Notice ]